A novel lentiviral packaging system enables production from a single-plasmid transfection instead of the standard four-plasmid process.

AGC Biologics signed a licensing agreement to use Asimov’s lentiviral packaging system, enabling production from a single-plasmid transfection.

Gradalis announces positive results from phase 2b VITAL trial of Vigil to treat patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer: Dallas Friday, January 16, ...

With the decision by the U.S. Food and Drug Administration and the European Commission to grant market authorization for Waskyratm, a gene therapy to treat Wiskott-Aldrich syndrome, AGC Biologics' ...

Opportunities in the mRNA quality monitoring market include the rising demand for QC due to the expansion of mRNA ...

This further establishes the global leadership of AGC Biologics' Milan Cell and Gene Center of Excellence in number of commercial products approvedMILAN--(BUSINESS WIRE)--#CGT--With the decision by ...

Single-use systems streamline CGT manufacturing by reducing cleaning validation and enabling quick changeovers, essential for ...

Women who received Elenagen plus chemotherapy lived significantly longer than those who received chemotherapy alone.

Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 ...

The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...

Protein scientists could improve reproducibility and coordination across the field by rallying around a small, shared set of ...

Wicklow students enjoyed another hugely successful outing at the Stripe Young Scientist & Technology Exhibition in the RDS, where inspired minds from several Garden County schools were honoured for ...